Z-1800-2013 Class II Terminated
FDA device recall Z-1800-2013 was initiated by Becton Dickinson & Co. on Jun 6, 2013 and is designated Class II. Reason for recall: Microbiological identification media may exhibit reduced levels of Vancomycin. The recall status is terminated (terminated Sep 3, 2013). Affected quantity: 45 cartons.
Recall Details
- Product Type
- Devices
- Report Date
- Jul 31, 2013
- Initiation Date
- Jun 6, 2013
- Termination Date
- Sep 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45 cartons
Product Description
BD BBL CDC Anaerobe 5% Sheep Blood Agar with Kanamycin and Vancomycin (KV), packaged in cartons of 100 plates, Catalog # 221736, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** CDC Anaerobe 5% Sheep Blood Agar with Kanamycin and Vancomycin is used for the selective isolation of fastidious and slow-growing, obligately anaerobic gram-negative bacteria from a variety of clinical and nonclinical materials.
Reason for Recall
Microbiological identification media may exhibit reduced levels of Vancomycin.
Distribution Pattern
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Code Information
Lot 3080083 Exp 6/4/13 Lot 3073075 Exp 5/29/13
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1800-2013
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026